Levaquin (levofloxacin) for treating penicillin-resistant pneumococcal pneumonia

The FDA just approved Levaquin (levofloxacin) for treating penicillin-resistant pneumococcal pneumonia.

This is the first antibiotic to be approved for this use.

Strep pneumoniae are becoming increasingly resistant to penicillins and other antibiotics.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote